PHILADELPHIA — FibroScan screening for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis could significantly improve patient diagnosis and care, as data presented at the American ...
WALTHAM, Mass. & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Echosens North America, a high-technology company offering the FibroScan ® portfolio of solutions, and ChronWell, a digital health and ...
The Tri-State’s TRUSTED news source. Click here to stay informed and subscribe to Herald-Dispatch. Click #isupportlocal for more information on supporting our local journalists. SCOTT DEPOT, W.Va. — ...
Just a few years ago, Grand Junction gastroenterologist Dr. William Shields was administering a lot of biopsies to diagnose the level of scarring in a patient's liver. The process involves a needle ...
This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development WESTBOROUGH, Mass., Sept. 8, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback